Daniel van Kammen

490 total citations
9 papers, 268 citations indexed

About

Daniel van Kammen is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Daniel van Kammen has authored 9 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 2 papers in Clinical Psychology and 2 papers in Psychiatry and Mental health. Recurrent topics in Daniel van Kammen's work include Neurotransmitter Receptor Influence on Behavior (2 papers), Child and Adolescent Psychosocial and Emotional Development (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Daniel van Kammen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (2 papers), Child and Adolescent Psychosocial and Emotional Development (2 papers) and Genetic Neurodegenerative Diseases (2 papers). Daniel van Kammen collaborates with scholars based in United States, United Kingdom and Australia. Daniel van Kammen's co-authors include Henriette Husum, Aleksander A. Mathé, Tom G. Bolwig, Evelien Termeer, David Pickar, William E. Bunney, Markku Linnoila, Philip T. Ninan, Steven M. Paul and Alec Roy and has published in prestigious journals such as Annals of the New York Academy of Sciences, Psychological Medicine and Neuropsychopharmacology.

In The Last Decade

Daniel van Kammen

8 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel van Kammen United States 6 136 75 53 45 41 9 268
H.‐W. Clement Germany 11 95 0.7× 72 1.0× 44 0.8× 40 0.9× 40 1.0× 17 367
Maria J. Sarrias Spain 9 176 1.3× 103 1.4× 71 1.3× 24 0.5× 84 2.0× 9 406
B.L. Jorissen Netherlands 6 104 0.8× 51 0.7× 55 1.0× 21 0.5× 56 1.4× 7 330
David Lozovsky United States 9 203 1.5× 64 0.9× 99 1.9× 39 0.9× 25 0.6× 12 386
D. Reina Italy 6 118 0.9× 75 1.0× 21 0.4× 75 1.7× 59 1.4× 6 305
Bryon Adinoff United States 8 111 0.8× 105 1.4× 25 0.5× 37 0.8× 37 0.9× 10 370
Janowsky Ds United States 10 132 1.0× 78 1.0× 92 1.7× 16 0.4× 70 1.7× 17 323
Clara Gobbo Italy 7 127 0.9× 84 1.1× 29 0.5× 40 0.9× 57 1.4× 8 294
D.J. Nutt United Kingdom 8 140 1.0× 37 0.5× 54 1.0× 37 0.8× 24 0.6× 14 332
Harold Landis United States 8 133 1.0× 97 1.3× 37 0.7× 28 0.6× 88 2.1× 10 355

Countries citing papers authored by Daniel van Kammen

Since Specialization
Citations

This map shows the geographic impact of Daniel van Kammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel van Kammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel van Kammen more than expected).

Fields of papers citing papers by Daniel van Kammen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel van Kammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel van Kammen. The network helps show where Daniel van Kammen may publish in the future.

Co-authorship network of co-authors of Daniel van Kammen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel van Kammen. A scholar is included among the top collaborators of Daniel van Kammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel van Kammen. Daniel van Kammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Anderson, Karen E., Erik van Duijn, David Craufurd, et al.. (2018). Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. Journal of Huntington s Disease. 7(4). 355–366. 65 indexed citations
2.
Evans, Kenneth, Karen E. Anderson, Beth Borowsky, et al.. (2008). Poster 4: The Functional Rating Scale Taskforce for Pre-Huntington's Disease: An Empirically-Driven Initiative for New Scale Development. Neurotherapeutics. 6(1). 205–205. 2 indexed citations
3.
Husum, Henriette, Daniel van Kammen, Evelien Termeer, Tom G. Bolwig, & Aleksander A. Mathé. (2003). Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line ‘Depressed’ Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects. Neuropsychopharmacology. 28(7). 1292–1299. 76 indexed citations
4.
Kammen, Daniel van. (1998). GABA and brain abnormalities in schizophrenia. Psychiatry Research Neuroimaging. 82(1). 25–35. 19 indexed citations
5.
Horrobin, David F., Sahebarao P. Mahadik, Ravinder Reddy, & Daniel van Kammen. (1996). In memoriam: Sukdeb Mukherjee MD, 1946–1995. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 1–1. 1 indexed citations
6.
Roy, Alec, Philip T. Ninan, David Pickar, et al.. (1985). CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychological Medicine. 15(2). 335–340. 53 indexed citations
7.
Buchsbaum, M.S., Victor I. Reus, Glenn C. Davis, et al.. (1982). ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHOPATHOLOGY. Annals of the New York Academy of Sciences. 398(1). 374–376. 1 indexed citations
8.
Davis, Glenn C., Monte S. Buchsbaum, Dieter Naber, et al.. (1982). ALTERED PAIN PERCEPTION AND CEREBROSPINAL ENDORPHINS IN PSYCHIATRIC ILLNESS. Annals of the New York Academy of Sciences. 398(1). 366–373. 40 indexed citations
9.
Karoum, Farouk, William E. Bunney, J. Christian Gillin, et al.. (1977). Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine. Biochemical Pharmacology. 26(7). 629–632. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026